Resmed Share Price Today
(NASDAQ: RMD)

Name: Resmed Share Price Today (NASDAQ: RMD) - Resmed Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Resmed share price is $223.85 & ₹19,119.92 as on 1 Apr 2025, 2.30 'hrs' IST

$223.85

▲

3.91

(1.78%)

Market is closed - opens 7 PM, 01 Apr 2025

View live Resmed share price in Dollar and Rupees. Guide to invest in Resmed stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Resmed, along with analyst recommendations, forecasts, and comprehensive financials.

Resmed share price movements

Today's Low: $215.87
Today's High: $225.00
$223.85
3.56%
Downside
Day's Volatility :4.06%
Upside
0.51%
52 Weeks Low: $172.19
52 Weeks High: $263.05
$223.85
23.08%
Downside
52 Weeks Volatility :34.54%
Upside
14.9%

Resmed (RMD) Returns

Period	Resmed Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.12%	6.1%	0.0%
6 Months	-6.24%	-4.7%	0.0%
1 Year	18.24%	-0.3%	0.0%
3 Years	-8.9%	5.8%	-15.4%

Resmed (RMD) Key Statistics

in dollars & INR

Previous Close	$219.94
Open	$219.11
Today's High	$225.0
Today's Low	$215.87
Market Capitalization	$32.9B
Today's Volume	$1.1M
52 Week High	$263.05
52 Week Low	$172.19
Revenue TTM	$4.9B
EBITDA	$1.7B
Earnings Per Share (EPS)	$8.46
PE Ratio	26.46
Dividend Yield	0.95%
Profit Margin	25.35%
Quarterly Earnings Growth YOY	0.65%
Return On Equity TTM	25.65%

How to invest in Resmed Stock (RMD) from India?

It is very easy for Indian residents to invest directly in Resmed from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Resmed stock in both Indian Rupees (INR) and US Dollars (USD). Search for Resmed or RMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Resmed or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Resmed shares which would translate to 0.004 fractional shares of Resmed as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Resmed, in just a few clicks!

Returns in Resmed (RMD) for Indian investors in Rupees

The Resmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Resmed investment value today

Current value as on today

₹1,20,692

Returns

₹20,692

(+20.69%)

Returns from Resmed Stock

₹18,239 (+18.24%)

Dollar Returns

₹2,453 (+2.45%)

Indian investors sentiment towards Resmed (RMD)

-4%

Period: Mar 1, 2025 to Mar 31, 2025. Change in 30 Days versus previous period

Search interest for Resmed Stock from India on INDmoney has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Resmed Stock (RMD Ticker)

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1266	-3.24	0.07%

Global Institutional Holdings in Resmed

Vanguard Group Inc
12.37%
BlackRock Inc
8.59%
State Street Corp
4.40%
Bank of New York Mellon Corp
3.70%
Geode Capital Management, LLC
2.69%
Morgan Stanley - Brokerage Accounts
2.64%

Analyst Recommendation on Resmed

Buy

63%Buy

36%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Resmed(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Resmed Stock (RMD)

What analysts predicted

Upside of 20.66%

Target:

$270.09

Current:

$223.85

Insights on Resmed Stock (Ticker Symbol: RMD)

Price Movement
In the last 7 days, RMD stock has moved up by 1.2%
Increasing Revenue
Resmed Inc. has shown strong revenue growth over the last 6 quarters, increasing from $963.03 million to $1.28 billion. This represents an average increase of 5.4% in revenue each quarter.
Increasing Net Profit
Resmed Inc. has shown a positive trend in its net profit over the last three quarters. The net profit increased from $292.23 million to $344.62 million, resulting in an average growth of 7.9% each quarter.
RMD vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 25.4% return, outperforming this stock by 7.2%
RMD vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 62.1% return, outperforming this stock by 71.3%
Price to Sales
Resmed Inc. is currently valued at a price-to-sales ratio of 6.7. This means that for every $1 of sales generated by Resmed, investors are willing to pay $6.7. In comparison, Intuitive Surgical, Inc. has a much higher price-to-sales ratio of 21.1, indicating that investors pay more for each $1 of sales from that company. This suggests that investors may see less growth potential in Resmed compared to Intuitive Surgical.

RMD Resmed Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.6B	↑ 11.38%
Net Income	$404.6M	↑ 28.2%
Net Profit Margin	15.52%	↑ 2.03%

	FY20	Y/Y Change
Revenue	$3.0B	↑ 13.44%
Net Income	$621.7M	↑ 53.65%
Net Profit Margin	21.02%	↑ 5.5%

	FY21	Y/Y Change
Revenue	$3.2B	↑ 8.11%
Net Income	$474.5M	↓ 23.67%
Net Profit Margin	14.84%	↓ 6.18%

	FY22	Y/Y Change
Revenue	$3.6B	↑ 11.93%
Net Income	$779.4M	↑ 64.26%
Net Profit Margin	21.78%	↑ 6.94%

	FY23	Y/Y Change
Revenue	$4.2B	↑ 18.02%
Net Income	$897.6M	↑ 15.15%
Net Profit Margin	21.25%	↓ 0.53%

	FY24	Y/Y Change
Revenue	$4.7B	↑ 10.95%
Net Income	$1.0B	↑ 13.75%
Net Profit Margin	21.79%	↑ 0.54%

	Q3 FY23	Q/Q Change
Revenue	$963.0M	↓ 14.17%
Net Income	$219.4M	↓ 4.46%
Net Profit Margin	22.78%	↑ 2.31%

	Q4 FY23	Q/Q Change
Revenue	$1.2B	↑ 20.74%
Net Income	$208.8M	↓ 4.84%
Net Profit Margin	17.96%	↓ 4.82%

	Q1 FY24	Q/Q Change
Revenue	$1.2B	↑ 2.94%
Net Income	$300.5M	↑ 43.91%
Net Profit Margin	25.1%	↑ 7.14%

	Q2 FY24	Q/Q Change
Revenue	$1.2B	↑ 2.19%
Net Income	$292.2M	↓ 2.75%
Net Profit Margin	23.89%	↓ 1.21%

	Q3 FY24	Q/Q Change
Revenue	$1.2B	↑ 0.11%
Net Income	$311.4M	↑ 6.54%
Net Profit Margin	25.43%	↑ 1.54%

	Q4 FY24	Q/Q Change
Revenue	$1.3B	↑ 4.7%
Net Income	$344.6M	↑ 10.68%
Net Profit Margin	26.88%	↑ 1.45%

	FY19	Y/Y Change
Profit	$1.5B	↑ 12.8%

	FY20	Y/Y Change
Profit	$1.7B	↑ 11.79%

	FY21	Y/Y Change
Profit	$1.8B	↑ 7.06%

	FY22	Y/Y Change
Profit	$2.0B	↑ 10.07%

	FY23	Y/Y Change
Profit	$2.4B	↑ 16.37%

	FY24	Y/Y Change
Profit	$2.7B	↑ 12.72%

	Q3 FY23	Q/Q Change
Profit	$600.1M	↓ 2.81%

	Q4 FY23	Q/Q Change
Profit	$646.9M	↑ 7.81%

	Q1 FY24	Q/Q Change
Profit	$681.6M	↑ 5.35%

	Q2 FY24	Q/Q Change
Profit	$704.3M	↑ 3.33%

	Q3 FY24	Q/Q Change
Profit	$717.2M	↑ 1.84%

	Q4 FY24	Q/Q Change
Profit	$751.3M	↑ 4.75%

	FY19	Y/Y Change
Operating Cash Flow	$459.1M	↓ 9.1%
Investing Cash Flow	$-1.1B	↑ 956.44%
Financing Cash Flow	$580.6M	↓ 156.55%

	FY20	Y/Y Change
Operating Cash Flow	$802.3M	↑ 74.76%
Investing Cash Flow	$-179.9M	↓ 83.28%
Financing Cash Flow	$-317.3M	↓ 154.64%

	FY21	Y/Y Change
Operating Cash Flow	$736.7M	↓ 8.17%
Investing Cash Flow	$-158.5M	↓ 11.9%
Financing Cash Flow	$-764.6M	↑ 140.99%

	FY22	Y/Y Change
Operating Cash Flow	$351.1M	↓ 52.34%
Investing Cash Flow	$-229.9M	↑ 45.09%
Financing Cash Flow	$-128.4M	↓ 83.21%

	FY23	Y/Y Change
Operating Cash Flow	$693.3M	↑ 97.44%
Investing Cash Flow	$-1.2B	↑ 404.46%
Financing Cash Flow	$422.9M	↓ 429.44%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$286.3M	↑ 20.57%
Investing Cash Flow	$-149.0M	↓ 87.16%
Financing Cash Flow	$-151.1M	↓ 19.86%

Resmed Technicals Summary

Sell

Neutral

Buy

Resmed is currently in a neutral trading position according to technical analysis indicators.

Resmed (RMD) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Resmed Inc.	-3.97%	-6.24%	18.24%	-8.9%	49.1%
Intuitive Surgical, Inc.	-12.65%	2.17%	25.43%	63.86%	217.67%
Alcon Ag	0.84%	-4.23%	15.74%	19.03%	91.66%
Baxter International Inc.	-1.81%	-7.26%	-21.4%	-54.64%	-58.37%
Becton, Dickinson And Company	0.27%	-5.22%	-6.14%	-11.32%	-1.81%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Resmed Inc.	26.46	26.46	1.43	9.46	0.26	0.14	0.01	35.77
Intuitive Surgical, Inc.	76.91	76.91	3.4	8.06	0.16	0.09	NA	46.08
Alcon Ag	46.31	46.31	2.86	3.24	0.05	0.03	0.0	43.58
Baxter International Inc.	133.76	NA	2.2	2.49	-0.04	0.02	0.02	13.63
Becton, Dickinson And Company	38.63	38.63	1.04	14.42	0.07	0.04	0.02	87.78

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Resmed Inc.	Buy	$32.9B	49.1%	26.46	25.35%
Intuitive Surgical, Inc.	Buy	$177.4B	217.67%	76.91	27.81%
Alcon Ag	Buy	$47.3B	91.66%	46.31	10.27%
Baxter International Inc.	Hold	$17.6B	-58.37%	133.76	-6.1%
Becton, Dickinson And Company	Buy	$65.8B	-1.81%	38.63	8.37%

Resmed Dividend announcements

Resmed Dividends March, 2025
In the quarter ending March,2025. Resmed has declared dividend of $0.53

About Resmed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Organization	Resmed
Employees	0
CEO	Mr. Michael J. Farrell BE, MBA, SM
Industry	Health Technology

Management People of Resmed

Name	Title
Mr. Michael J. Farrell BE, MBA, SM	CEO & Chairman
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD	Founder, Chair Emeritus & Director
Mr. Brett A. Sandercock	Chief Financial Officer
Mr. Michael J. Rider	Chief Legal Officer & Secretary
Mr. Justin Leong	Chief Product Officer
Mr. Kaushik Ghoshal	Chief Commercial Officer - SaaS
Mr. Alastair Robertson	Chief Information Officer
Mr. Jim Ellis	Chief Compliance Officer
Ms. Yvonne-Katrin Pucknat	Chief Marketing Officer
Ms. Vered Keisar	Chief People Officer

Important FAQs about investing in RMD Stock from India :

What is Resmed share price today?

Resmed share price today stands at $223.85, Open: $219.11 ; Previous Close: $219.94 ; High: $225.00 ; Low: $215.87 ; 52 Week High: $263.05 ; 52 Week Low: $172.19.

The stock opens at $219.11, after a previous close of $219.94. The stock reached a daily high of $225.00 and a low of $215.87, with a 52-week high of $263.05 and a 52-week low of $172.19.

Can Indians buy Resmed shares?

Yes, Indians can invest in the Resmed (RMD) from India.

With INDmoney, you can buy Resmed at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Resmed at zero transaction cost.

How can I buy Resmed shares from India?

It is very easy to buy Resmed from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Resmed (RMD) be purchased?

Yes, you can buy fractional shares of Resmed with INDmoney app.

What are the documents required to start investing in Resmed stocks?

To start investing in Resmed, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.